Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy.

Saved in:
Bibliographic Details
Title: Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy.
Authors: Moussa, Mohammad Jad1 (AUTHOR) mmoussa1@mdanderson.org, Khandelwal, Jaanki2 (AUTHOR), Wilson, Nathaniel R.3 (AUTHOR), Naik, Sagar A.4 (AUTHOR), Subbiah, Vivek5 (AUTHOR), Campbell, Matthew T.1 (AUTHOR), Msaouel, Pavlos1 (AUTHOR), Singh, Parminder6 (AUTHOR), Alhalabi, Omar1 (AUTHOR) oalhalabi@mdanderson.org
Source: Current Oncology. Jun2024, Vol. 31 Issue 6, p3342-3349. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:11980052
DOI:10.3390/curroncol31060254